Viewing Study NCT06972602


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-01-29 @ 6:48 AM
Study NCT ID: NCT06972602
Status: RECRUITING
Last Update Posted: 2025-05-15
First Post: 2025-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Sponsor: Eye & ENT Hospital of Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinoblastoma View
None Retinoblastoma, Recurrent View
Keywords: